WHEREAS, Great strides have been made in research and
treatment for rare diseases as a result of the Orphan Drug Act;
and
WHEREAS, The United States Food and Drug Administration and
the National Institutes of Health have established special
offices to advocate for rare disease research and treatments;
and
WHEREAS, The National Organization for Rare Disorders is an
organization established in 1983 to provide services to patients
with rare diseases and advocate on behalf of patients with rare
diseases; and
WHEREAS, The National Organization for Rare Disorders was a
primary force behind the enactment of the Orphan Drug Act and
remains a critical public voice for people with rare diseases;
and
WHEREAS, The National Organization for Rare Disorders
sponsors "Rare Disease Day" in the United States to increase
public awareness of rare diseases; and
WHEREAS, "Rare Disease Day" has become a global event
occurring annually on the last day of February; therefore be it
RESOLVED, That the House of Representatives designate May 7,
2019, as "Rare Disease Day" in Pennsylvania; and be it further
RESOLVED, That the House of Representatives join millions of
people around the world in observing "Rare Disease Day" and
finding ways to work together to provide the different kinds of
care that people living with a rare disease need.
20190HR0316PN1734 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26